Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-15 Sale |
2025-05-16 8:57 pm |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
36,508 | $44.35 | $1,619,130 | 1,279,416 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-22 7:23 pm |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
11,437 | $21 | $240,177 | 1,260,578 (Direct) |
View |
| 2022-02-22 Sale |
2022-02-24 8:22 pm |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
84,515 | $19.56 | $1,653,113 | 1,220,036 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 8:32 pm |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
20,770 | $24.98 | $518,794 | 1,288,127 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-29 Option Award |
2025-05-30 7:13 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
9,812 | $0 | 1,289,228 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-16 8:57 pm |
2019-05-23 2026-05-22 |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
36,508 | $0 | 1,279,416 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-16 8:57 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
15,874 | $20.5 | 1,279,416 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-16 8:57 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
20,634 | $19.77 | 1,279,416 (Direct) |
View |
| 2025-04-30 Option Award |
2025-04-30 4:30 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
62,500 | $0 | 1,040,888 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-04 4:44 pm |
N/A 2035-03-02 |
Ovid Therapeutics Inc. | OVID | PAPADOPOULOS STELIOS Director |
90,000 | $0 | 90,000 (Direct) |
View |
Ownership |
2025-03-04 4:42 pm |
N/A N/A |
Ovid Therapeutics Inc. | OVID | PAPADOPOULOS STELIOS Director |
0 | $0 | 200,000 (Direct) |
View |
| 2024-05-31 Option Award |
2024-06-04 8:21 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
18,838 | $0 | 1,279,416 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 7:23 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
11,686 | $19.57 | 1,260,578 (Direct) |
View |
| 2024-05-20 Exercise |
2024-05-22 7:23 pm |
2017-05-25 2024-05-24 |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
11,686 | $0 | 1,260,578 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-21 4:23 pm |
N/A 2034-05-19 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2024-05-16 Option Award |
2024-05-17 4:38 pm |
N/A 2034-05-15 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:19 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
250,000 | $1.6 | 978,388 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:28 pm |
N/A 2033-08-09 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-13 4:50 pm |
N/A 2033-06-12 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 9:13 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
20,718 | $0 | 1,260,329 (Direct) |
View |
| 2023-04-13 Option Award |
2023-04-14 4:39 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
222,198 | $0.9001 | 728,388 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:13 pm |
N/A N/A |
BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director |
2,255 | $0 | 38,301 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:18 pm |
N/A 2032-06-09 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 9:19 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
19,575 | $0 | 1,239,611 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-01 4:12 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
2,222,222 | $0.36 | 5,061,929 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-02 5:27 pm |
N/A N/A |
BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director |
1,275 | $0 | 36,046 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-15 4:43 pm |
N/A 2031-06-13 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-27 Option Award |
2021-05-28 8:26 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
16,424 | $0 | 1,304,551 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 8:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
40,000 | $3.38 | 1,288,127 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 8:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
40,000 | $6.3 | 1,288,127 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 8:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
40,000 | $3.13 | 1,288,127 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 8:32 pm |
2016-05-26 2023-05-25 |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
120,000 | $0 | 1,288,127 (Direct) |
View |
| 2020-12-04 Option Award(A) |
2021-01-27 8:16 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
793,528 | $0.6301 | 2,839,707 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 4:21 pm |
2020-12-04 2025-12-04 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
595,146 | $0.125 | 2,581,875 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 4:21 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
793,528 | $0.6301 | 2,581,875 (Direct) |
View |
| 2020-11-24 Other |
2020-11-27 4:05 pm |
N/A N/A |
Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner |
255,094 | $0 | 2,875,000 (Indirect) |
View |
Ownership |
2020-10-23 1:23 pm |
N/A N/A |
Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner |
0 | $0 | 2,875,000 (Indirect) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:40 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
23,250 | $0 | 23,250 (Direct) |
View |